UCB - Pe Kurs-Gewinn





Pe Veränderung Datum
Alcon AG 42.44 6.03 2026-06
Almirall 79.43 0.3 2025-12
Amarin 91.05 88.3 2023-06
argenx SE 33.43 2.1 2026-09
AstraZeneca 24.63 0.71 2026-09
Bayer 4.14 0.74 2026-06
Genmab 16.04 1.05 2026-06
GlaxoSmithKline 9.72 0.9 2026-09
GRIFOLS 14.71 3.73 2026-06
Hikma Pharmaceutical 10.43 3.72 2025-12
Lakefront Biotherapeutics 2.68 0.14 2026-06
Lonza 34.34 2.58 2025-12
Merck 17.21 4.47 2026-06
Novartis 19.17 3.24 2026-09
Orion 17.23 1.3 2026-06
Recordati 22.75 5.09 2026-06
Roche Holding 16.48 0.39 2026-06
Sanofi 22.34 3.38 2026-09
UCB 29.7 5.52 2025-12
Unibail Rodamco 10.36 0.43 2025-12